Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hypophosphatemia induced by intravenous administration of saccharated ferric oxide
Yuichiro Shimizu, Yuko Tada, Mika Yamauchi, et al.
Bone (2009) Vol. 45, Iss. 4, pp. 814-816
Closed Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Regulation and Function of the FGF23/Klotho Endocrine Pathways
Aline Martin, Valentin David, L. Darryl Quarles
Physiological Reviews (2012) Vol. 92, Iss. 1, pp. 131-155
Open Access | Times Cited: 552
Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production
Valentin David, Aline Martin, Tamara Isakova, et al.
Kidney International (2015) Vol. 89, Iss. 1, pp. 135-146
Open Access | Times Cited: 442
Update on fibroblast growth factor 23 in chronic kidney disease
Myles Wolf
Kidney International (2012) Vol. 82, Iss. 7, pp. 737-747
Open Access | Times Cited: 367
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice
Emily Farrow, Xijie Yu, Lelia J. Summers, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 46
Open Access | Times Cited: 355
FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease
Rayko Evstatiev, Philippe Marteau, Tariq Iqbal, et al.
Gastroenterology (2011) Vol. 141, Iss. 3, pp. 846-853.e2
Open Access | Times Cited: 330
Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
Erik A. Imel, Munro Peacock, Amie K. Gray, et al.
The Journal of Clinical Endocrinology & Metabolism (2011) Vol. 96, Iss. 11, pp. 3541-3549
Open Access | Times Cited: 280
Tumor-induced osteomalacia: An important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature
Yan Jiang, Weibo Xia, Xiaoping Xing, et al.
Journal of Bone and Mineral Research (2012) Vol. 27, Iss. 9, pp. 1967-1975
Open Access | Times Cited: 213
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Daniel Edmonston, Myles Wolf
Nature Reviews Nephrology (2019) Vol. 16, Iss. 1, pp. 7-19
Closed Access | Times Cited: 204
Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
Jodie L. Babitt, Michele F. Eisenga, Volker H. Haase, et al.
Kidney International (2021) Vol. 99, Iss. 6, pp. 1280-1295
Open Access | Times Cited: 163
Rickets
Thomas O. Carpenter, Nick J. Shaw, Anthony A. Portale, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 165
Approach to the Hypophosphatemic Patient
Erik A. Imel, Michael J. Econs
The Journal of Clinical Endocrinology & Metabolism (2012) Vol. 97, Iss. 3, pp. 696-706
Open Access | Times Cited: 154
FGF-23: More than a regulator of renal phosphate handling?
Harald Jüppner, Myles Wolf, Isidro B. Salusky
Journal of Bone and Mineral Research (2010) Vol. 25, Iss. 10, pp. 2091-2097
Open Access | Times Cited: 153
Medication-induced hypophosphatemia: a review
Georgé Liamis, Haralampos J. Milionis, Moses Elisaf
QJM (2010) Vol. 103, Iss. 7, pp. 449-459
Open Access | Times Cited: 149
Iron-induced hypophosphatemia
Heinz Zoller, Benedikt Schaefer, Bernhard Glodny
Current Opinion in Nephrology & Hypertension (2017) Vol. 26, Iss. 4, pp. 266-275
Closed Access | Times Cited: 138
X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
Yuka Kinoshita, Seiji Fukumoto
Endocrine Reviews (2018) Vol. 39, Iss. 3, pp. 274-291
Open Access | Times Cited: 138
Fibroblast growth factor 23: state of the field and future directions
Nisan Bhattacharyya, William H Chong, Rachel I. Gafni, et al.
Trends in Endocrinology and Metabolism (2012) Vol. 23, Iss. 12, pp. 610-618
Open Access | Times Cited: 116
68Ga DOTATATE PET/CT is an Accurate Imaging Modality in the Detection of Culprit Tumors Causing Osteomalacia
Jingjing Zhang, Zhaohui Zhu, Dingrong Zhong, et al.
Clinical Nuclear Medicine (2015) Vol. 40, Iss. 8, pp. 642-646
Closed Access | Times Cited: 91
Tumor-Induced Osteomalacia: A Systematic Clinical Review of 895 Cases
Ariadne Bosman, Andrea Palermo, Julien Vanderhulst, et al.
Calcified Tissue International (2022) Vol. 111, Iss. 4, pp. 367-379
Open Access | Times Cited: 62
Tumor-induced Osteomalacia: A Comprehensive Review
Salvatore Minisola, Seiji Fukumoto, Weibo Xia, et al.
Endocrine Reviews (2022) Vol. 44, Iss. 2, pp. 323-353
Open Access | Times Cited: 52
Recent advances in renal phosphate handling
Emily Farrow, Kenneth E. White
Nature Reviews Nephrology (2010) Vol. 6, Iss. 4, pp. 207-217
Open Access | Times Cited: 120
Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice
Yukiko Aono, Hisashi Hasegawa, Y. Yamazaki, et al.
Journal of Bone and Mineral Research (2010) Vol. 26, Iss. 4, pp. 803-810
Open Access | Times Cited: 103
Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
Sean A. Hardy, X. Vandemergel
International Journal of Rheumatology (2015) Vol. 2015, pp. 1-6
Open Access | Times Cited: 75
Severe hypophosphataemia after intravenous iron administration
Gurpreet Anand, Christoph Schmid
BMJ Case Reports (2017), pp. bcr2016219160-bcr2016219160
Open Access | Times Cited: 74
Hypophosphatemic Rickets
Martin Bitzan, Paul Goodyer
Pediatric Clinics of North America (2018) Vol. 66, Iss. 1, pp. 179-207
Closed Access | Times Cited: 66
FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment
Seiji Fukumoto
Journal of Molecular Endocrinology (2020) Vol. 66, Iss. 2, pp. R57-R65
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top